⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 25, 2025TrialsOpen Access

A WeChat mini-program-based intervention for orofacial myofunctional therapy in adults with obstructive sleep apnea–hypopnea syndrome: a randomized controlled trial protocol

Yuqing Ren Mao Mao X M Qi Zhifei Yin

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

ClinicalTrials.gov ChiCTR2300067637. Registered on January 16, 2023.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Ren et al. (2025) studied this question.

synapsesocial.com/papers/694037a52d562116f290a552 https://doi.org/10.1186/s13063-025-08905-8

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A WeChat mini-program-based intervention for orofacial myofunctional therapy in adults with obstructive sleep apnea–hypopnea syndrome: a randomized controlled trial protocol2025
2Efficacy and adherence of mobile health-based myofunctional therapy for obstructive sleep apneaRandomized Controlled Trial · 2026
3Myofunctional therapy in sleep disorders: a systematic reviewSystematic Review · 2026 · 2 citations
4Effectiveness of myofunctional therapy combined with breathing exercises in the treatment of obstructive sleep apneaOriginal Research · 2026
5Effectiveness of a myofunctional therapy program in the treatment of mouth breathing in patients with dental malocclusion: a pilot clinical trialPilot Study · 2026

More related papers

Efficacy of oral myofunctional therapy in middle‐aged to elderly patients with obstructive sleep apnoea treated with continuous positive airway pressure2020
Prospective, randomized, control group study of active myofascial therapy for the treatment of snoring and mild obstructive sleep apnea2024
Community-based intervention for obstructive sleep apnea in the general population: a randomized controlled trial2024

More from Trials

ABCD-Trial: study protocol for a randomized, double-blind, placebo-controlled study in patients with Amyotrophic lateral sclerosis for the evaluation of efficacy and safety of B-Cell Depletion with rituximab (ABCD)Tue,
AgeX trials of extending the breast screening age range: study protocol for the follow-up phase (2025–2033)Mon,